Goldman Sachs Group »

Compass Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $322k 207k 1.56
2023-09-30 $434k 220k 1.97
2023-06-30 $342k 108k 3.18
2023-03-31 $649k 199k 3.27